The Leukemia & Lymphoma Society Selects Appian’s Award-Winning BPM Suite to Automate Co-Pay Assistance Program
Industry Leading BPMS Provides a Comprehensive Solution to Simplify and Streamline Application Process
Vienna, VA., May 2, 2007 – Appian, the leading provider of Business Process Management Suites (BPMS), today announced that The Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to funding blood cancer research, education and patient services, selected Appian Enterprise to automate and structure the application process for its Co-Pay Assistance Program. The Society’s Co-Pay Assistance Program offers assistance to patients toward private health insurance premiums, private insurance co-pay obligations, and Medicare Part B, Medicare Plan D, Medicare Supplementary Health Insurance and Medicare Advantage premium or co-pay obligations. The organization chose Appian Enterprise to support the entire applicant workflow process, supporting online, faxed and mailed applications.
“Appian Enterprise gives us the capacity to implement a flexible yet robust framework for handling our co-pay applicants’ needs,” said Jon Lowell, the Society’s Chief Information Officer. “We chose Appian because it enables us to automate and optimize both our co-pay and other business processes from beginning to end and helps ensure that we are best serving our constituents.”
Using Appian’s leading BPMS, the Society is streamlining and automating its entire application process to better serve its constituents and reduce operating costs. This increased efficiency also enables the organization to more effectively respond to applicant queries and address its constituents’ needs. As the only BPM solution to address both application and human interactions, Appian Enterprise is enabling the Society to structure applicant processes as well as the guidelines for handling and evaluating all applications, delivering a uniform system for delivering benefits.
Appian’s award-winning BPMS is the industry’s only enterprise-class BPM solution to combine best-of-breed process management with broad collaboration and strong analytics functionality. Providing organizations with the industry’s most sophisticated platform for rapidly developing and deploying next-generation composite process applications, Appian Enterprise enables customers to increase operational efficiencies by managing, tracking and implementing procedures to support its application processes.
“Volunteer establishments are faced with the daunting task of structuring ever changing and fluid organizations of people and processes,” said Matt Calkins, CEO at Appian. “Appian’s BPMS provides the tools necessary to automate processes seamlessly and effectively, enabling The Leukemia & Lymphoma Society to efficiently serve its constituents and ensuring that the organization is attaining its mission.”
As the foundation for documenting, controlling, automating and reporting on business processes, Appian Enterprise provides the scalability to quickly automate critical processes. The industry-leading Appian Enterprise BPM suite provides fully integrated process, knowledge and analytics capabilities to drive quantifiable ROI and expedite the delivery of next-generation, process-driven solutions. Appian Enterprise enables customers to automate, execute and optimize cross-functional business processes from beginning to end.
Appian Enterprise is a comprehensive suite that provides fully integrated process, knowledge and analytics capabilities to drive quantifiable ROI and expedite the delivery of next-generation, process-driven solutions.
About the Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society, headquartered in White Plains, NY, with 66 chapters in the United States and Canada, is the world’s largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The Society’s mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested more than $486 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, the Society made 4.2 million contacts with patients, caregivers and healthcare professionals.
For more information about blood cancer, visit www.LLS.org or call the Society’s Information Resource Center (IRC), a call center staffed by master’s level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.
Appian provides a leading low-code software development platform that enables organizations to rapidly develop powerful and unique applications. The applications created on Appian’s platform help companies drive digital transformation and competitive differentiation. For more information, visit www.appian.com.